Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AB, accuracy, ACME, advice, Alder, analytical, anniversary, Annora, anticompetitive, apremilast, atypical, autoinjector, AVSOLATM, backup, BAFF, Behcet, BeiGene, BioPharma, blocker, Blue, Brexit, bundled, buyer, CANDOR, Canyon, Castillo, celebrate, Celgene, Cesar, CGRP, chosen, Cleveland, cloud, cofounder, complement, comprised, conjugate, consortium, contemplate, contractile, contrast, convenience, costimulatory, Council, cured, curently, curiae, DARZALEX, deposit, disconnect, DOJ, door, downstream, DRL, eculizumab, ejection, embedded, eptinezumab, estate, evidentiary, exploring, EY, fast, formatted, fraction, Fraternal, gastric, GDPR, genital, Glenmark, griffith, hemoglobinuria, hemolytic, HFrEF, HHS, highest, HMO, homolog, immunogenicity, implicit, improperly, Indemnity, inflation, Inline, insufficient, insulin, interact, interactive, interval, intervenor, intervention, invention, Irrevocable, judgement, Kashiv, Kinney, Kirsten, KPH, lending, library, Lodge, lone, lookback, lymphocyte, lymphocytic, Maine, male, Mankind, Mayor, MDL, Miami, misrepresentation, MN, Momenta, MRD, MSP, multidistrict, mutation, myotrope, NaN, nearest, negligent, newest, nocturnal, NSCLC, nuclear, Nuevolution, obstructive, Officerand, oncogene, opposed, Orange, Otezla, otezla®, outage, overnight, overpaid, oversaw, overturned, overturning, panel, paroxysmal, path, payor, penalize, perspective, peter, petitioner, Pharmascience, phosphodiesterase, Pipe, platform, play, PNH, preemptive, preferential, preliminarily, prespecified, presumptively, Prinston, proceeding, prolonged, pulmonary, rat, real, refine, reply, rescheduled, restraining, revert, role, Rozibafusp, Run, Samsung, sarcoma, Scandinavian, sequencing, Sherwood, Shield, Shilpa, Slate, slated, sponte, St, stake, standing, stimulator, stressed, sua, sublease, successor, summer, SureClick, SwissBioSim, tableting, Tanvex, TDAPA, thicket, thrombocytopenia, thrombopoietin, UFCW, unanimously, unconstitutional, Unichem, unopposed, unrest, upholding, uremic, USPTO, vehicle, vendor, viral, waived, Wedbush, workforce
Removed:
ABB, accreted, Africa, African, aggregating, agile, attempting, automotive, Barr, BiTE, bortezomib, brand, Brazil, Cambridge, clarifying, compliant, composition, concluding, confronted, construct, coronary, darbepoetin, deadline, debated, declining, deliberately, disclosing, disposed, diversion, Donald, eligibility, ENDEAVOR, erythropoietin, ESPO, exchanged, excluding, exerting, frank, Friedrichshafen, fusion, gave, granting, herringer, improving, inclined, influence, infrastructure, insignificant, Insulet, integration, Lek, lengthen, lifecycle, lift, LUMICEF, Mexico, mid, monotherapy, North, occupy, older, Philadelphia, premium, preserving, prospectively, purifying, qualification, randomized, ranged, reallocate, recombinant, recommending, reinstated, reinvested, reliable, removing, renal, repealing, residential, ROMIPLATE, sBLA, separation, serving, sham, Sherman, sponsor, statute, subset, suspended, switching, TOWER, transformation, Trump, TRW, undistributed, vacated, variation, venture, vertically, withholding, Zealand, ZF
Filing tables
Filing exhibits
- 10-K Annual report
- 2.3 Amendment to No. 2 to the Asset Purchase Agreement Between Amgen and Celgene
- 2.4 Letter Agreement - Treatment of Certain Product Inventory
- 4.29 Description of Securities
- 10.4 Form of Grant of Stock Option Agreement
- 10.5 Form of Restricted Stock Unit Agreement
- 10.7 Form of Performance Unit Agreement
- 10.8 Director Equity Incentive Program
- 10.10 Form of Restricted Stock Unit Agreement
- 10.11 Form of Cash-settled Restricted Stock Unit Agreement
- 10.14 Second Amendment to Supplemental Retirement Plan
- 10.21 Second Amendment to Nonqualified Deferred Compensation Plan
- 10.41 Collaboration Agreement
- 10.42 Guarantee Agreement
- 21 Subsidiaries of the Company
- 31 Rule 13A-14(A) Certifications
- 32 Section 1350 Certifications
- Download Excel data file
- View Excel data file
Related press release
Associated AMGN transcripts
AMGN similar filings
Filing view
External links
SECOND AMENDMENT TO THE
AMGEN INC. SUPPLEMENTAL RETIREMENT PLAN
AS AMENDED AND RESTATED EFFECTIVE OCTOBER 16, 2013
The Amgen Inc. Supplemental Retirement Plan, as Amended and Restated Effective October 16, 2013 (the “Plan”), is hereby amended, effective October 23, 2019, as follows:
1. | Section 2.27 is amended by adding the following at the end thereof: |
If you were employed in the United States by Celgene Corporation or any affiliate of Celgene Corporation (collectively, “Celgene”) immediately preceding the Closing Date (as defined in the Asset Purchase Agreement by and among Celgene Corporation, as Seller, and Amgen Inc., as Purchaser, Dated as of August 25, 2019) and effective as of the Closing Date, you were offered and you accepted employment with the Company, then for purposes of calculating your Years of Service under the Plan, you will receive credit for your years of service with Celgene and with Celgene-recognized predecessors prior to the Closing Date.
To record this Second Amendment to the Plan as set forth herein, the Company has caused its authorized officer to execute this document this 23rd day of October, 2019.
AMGEN INC.
By: | /s/ Lori A. Johnston |
Name: Lori A. Johnston Title: Executive Vice President, Human Resources |